Desvenlafaxine
NDC 51991-311, Desvenlafaxine Succinate, tablet, extended release, from Breckenridge Pharmaceutical, Inc.
- Product NDC
- 51991-311
- Status
- Listed
- Labeler
- Breckenridge Pharmaceutical, Inc
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA204003
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/51991-311 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DESVENLAFAXINE SUCCINATE50 mg/1
Pharmacologic classes
Cytochrome P450 2D6 Inhibitors [MoA]; Norepinephrine Uptake Inhibitors [MoA]; Serotonin Uptake Inhibitors [MoA]; Serotonin and Norepinephrine Reuptake Inhibitor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 51991-311-01 | 51991031101 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (51991-311-01) |
| 51991-311-10 | 51991031110 | 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (51991-311-10) |
| 51991-311-11 | 51991031111 | 100 TABLET, EXTENDED RELEASE in 1 CARTON (51991-311-11) |
| 51991-311-14 | 51991031114 | 14 TABLET, EXTENDED RELEASE in 1 BOTTLE (51991-311-14) |
| 51991-311-33 | 51991031133 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (51991-311-33) |
| 51991-311-80 | 51991031180 | 80 TABLET, EXTENDED RELEASE in 1 CARTON (51991-311-80) |
| 51991-311-90 | 51991031190 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (51991-311-90) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/25bdfc41-c7cb-4d16-b6a8-f102f9b8c984NADAC price for package 51991031110
GET /v1/drugs/nadac/51991031110NADAC price for package 51991031133
GET /v1/drugs/nadac/51991031133NADAC price for package 51991031190
GET /v1/drugs/nadac/51991031190
Use it
Look up 51991-311 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/51991-311 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 51991-311. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.